Why Hims & Hers stock is failing to retain menopause gains and what comes next?

Core Insights - Hims & Hers Health Inc has announced its expansion into menopause-related treatments, targeting a large and underserved market [1] - The initial positive market reaction is beginning to fade, indicating potential volatility in stock performance [1] Company Summary - Hims & Hers Health Inc (NYSE: HIMS) is focusing on menopause-related treatments, which represents a significant opportunity within the healthcare sector [1] - The company is entering a market that has been largely neglected, suggesting potential for growth and increased revenue streams [1] Industry Summary - The menopause treatment market is characterized as large and underserved, highlighting a gap in existing healthcare offerings [1] - The expansion into this area may position Hims & Hers Health Inc favorably against competitors who have not yet addressed this demographic [1]